+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Third-party Medical Testing Services Market - Global Forecast 2026-2032- Product Image
Third-party Medical Testing Services Market - Global Forecast 2026-2032- Product Image
New

Third-party Medical Testing Services Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6080033
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Third-party medical testing services have become fundamental to modern healthcare and life sciences, supporting clinicians, researchers, and administrators aiming to deliver efficient, reliable, and integrated diagnostic workflows. As healthcare transformation accelerates, partnering with adaptable third-party labs enables organizations to respond to evolving needs in diagnostics and service delivery.

Market Snapshot: Third-party Medical Testing Services

The third-party medical testing services market is witnessing significant growth, moving from USD 3.94 billion in 2025 to USD 4.30 billion in 2026 and projected to reach USD 7.84 billion by 2032, reflecting a CAGR of 10.31%. Market expansion is driven by rising demand for high-complexity assays, increased integration with digital health solutions, and a heightened focus on rapid, accurate results. Providers and health systems are responding to evolving clinical demands and the pursuit of operational resilience.

Scope & Segmentation

This report delivers a comprehensive analysis tailored for executive decision-makers. Coverage spans operational models, service offerings, and emerging trends shaping the third-party medical testing services sector:

  • Diagnostic Types: Routine chemistry, immunoassays, molecular diagnostics, genetic analysis, microbiology, infectious disease detection, toxicology, drug monitoring
  • Service Models: Centralized reference labs, hybrid arrangements, decentralized and community-based options, mobile and at-home sample collection
  • Customer Groups: Health systems, physician networks, public health agencies, biopharma sponsors, digital health entities, contract research organizations
  • Complexity Levels: Routine and specialized assays, high-complexity diagnostics, advanced molecular and genetic testing panels
  • Regional Markets: North America, Europe, Asia-Pacific, Middle East, Africa, Latin America
  • Technologies & Workflows: Automation, robotics, digital integration, advanced specimen logistics, accessioning, validated digital reporting, cybersecurity
  • Supply Chain & Compliance: Standardized logistics, resilient sourcing strategies, privacy and data security, accreditation, evolving regulatory frameworks

Key Takeaways: Actionable Insights for Senior Leaders

  • Third-party medical testing now operates as a vital component of healthcare infrastructure, extending access to advanced diagnostics and accelerating delivery in both clinical and research settings.
  • Buyers increasingly demand interoperability with electronic health records, assurance of secure data, and the flexibility to support shifting care models and decentralized workflows.
  • Automation and digitization underpin competitive advantage, with labs differentiating themselves through seamless integration, reliable reporting, and responsive communication channels for clients across the care continuum.
  • Diverse customer groups have distinct priorities, from advanced clinical decision support for complex testing to network reliability for high-volume, routine diagnostics.
  • Regional trends influence market development: North America focuses on digitization and compliance, Europe seeks standardized processes, and Asia-Pacific is modernizing rapidly but inconsistently.
  • Procurers are favoring end-to-end partnership models, emphasizing robust analytical quality, compliance across geographies, and integrated service experiences.

Tariff Impact: Navigating Supply Chain Volatility

Upcoming changes to U.S. tariffs in 2025 add further complexity to the procurement of reagents, instruments, and consumables. These shifts challenge providers to review their inventory strategies, adopt dual supplier qualifications, and implement transparent pass-through practices to maintain service quality. Organizational agility and supply chain resilience will be crucial to weather volatility and keep pace with customer expectations.

Methodology & Data Sources

This study applies a triangulated research methodology, combining in-depth secondary sources with insights from executive stakeholder interviews and public company disclosures. Cross-verification with accreditation and market policy documents ensures reliable, current intelligence targeting operational, regulatory, and technical market drivers.

Why This Report Matters

  • Enables executives to identify pivotal shifts in service delivery models, technical capabilities, and buyer needs for strategic sourcing and partnership decisions.
  • Provides clarity on key market segments, regional variances, and regulatory and technology trends relevant to senior leadership objectives.
  • Equips decision-makers with actionable frameworks to navigate cost pressures, supply chain disruptions, and integration demands throughout the evolving testing landscape.

Conclusion

As third-party medical testing solidifies its role in healthcare and research, providers who invest in automation, operational resilience, and strong clinical support will position themselves to capture value in a complex market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Third-party Medical Testing Services Market, by Test Type
8.1. Clinical Chemistry
8.1.1. Automated Chemistry Analyzers
8.1.2. Point Of Care Chemistry Testing
8.2. Hematology
8.3. Histopathology
8.4. Immunology
8.5. Microbiology
8.6. Molecular Diagnostics
8.6.1. Next Generation Sequencing
8.6.2. PCR
9. Third-party Medical Testing Services Market, by Technology
9.1. Immunoassays
9.2. Mass Spectrometry
9.3. Microscopy
9.4. PCR
9.4.1. Digital PCR
9.4.2. Quantitative PCR
9.5. Sequencing
10. Third-party Medical Testing Services Market, by Sample Type
10.1. Blood
10.1.1. Plasma
10.1.2. Serum
10.1.3. Whole Blood
10.2. Saliva
10.3. Tissue
10.4. Urine
11. Third-party Medical Testing Services Market, by End User
11.1. Academic And Research Institutes
11.2. Diagnostic Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Pharmaceutical And Biotech Companies
12. Third-party Medical Testing Services Market, by Application
12.1. Cardiology
12.2. Genetic Testing
12.3. Infectious Diseases
12.4. Neurology
12.5. Oncology
12.5.1. Liquid Biopsy
12.5.2. Tissue Biopsy
13. Third-party Medical Testing Services Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Third-party Medical Testing Services Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Third-party Medical Testing Services Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Third-party Medical Testing Services Market
17. China Third-party Medical Testing Services Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. ARUP Laboratories LLC
18.6. Bio-Reference Laboratories Inc
18.7. Cerba Healthcare SA
18.8. Cerberus Diagnostics Inc
18.9. Charles River Laboratories International Inc
18.10. Element Materials Technology Ltd
18.11. Eurofins Scientific SE
18.12. Fulgent Genetics Inc
18.13. ICON plc
18.14. Intertek Group plc
18.15. IQVIA Holdings Inc
18.16. Labcorp Holdings Inc
18.17. Mayo Foundation for Medical Education and Research
18.18. Medpace Holdings Inc
18.19. NeoGenomics Laboratories Inc
18.20. OPKO Health Inc
18.21. PPD Inc
18.22. Quest Diagnostics Incorporated
18.23. SGS SA
18.24. Sonic Healthcare Limited
18.25. SYNLAB AG
18.26. TÜV SÜD AG
18.27. Unilabs Holding SA
18.28. WuXi AppTec Co Ltd
List of Figures
FIGURE 1. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY AUTOMATED CHEMISTRY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY AUTOMATED CHEMISTRY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY AUTOMATED CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY POINT OF CARE CHEMISTRY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY POINT OF CARE CHEMISTRY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY POINT OF CARE CHEMISTRY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY LIQUID BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY LIQUID BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 179. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 181. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 183. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 199. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 200. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 201. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 203. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 204. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 205. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 225. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 226. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 228. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 229. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 230. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 232. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. ASEAN THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 234. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 236. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 237. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 238. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 240. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 241. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 242. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 244. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. GCC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 258. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 260. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 261. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 262. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 263. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 264. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 265. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 266. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 268. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. BRICS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 270. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 272. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 273. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 274. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 276. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 277. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 278. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 280. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 281. G7 THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 282. NATO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. NATO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 284. NATO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 285. NATO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 286. NATO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. NATO THIRD-PARTY MEDICAL TESTING SERVICES MARKET

Companies Mentioned

The key companies profiled in this Third-party Medical Testing Services market report include:
  • ARUP Laboratories LLC
  • Bio‑Reference Laboratories Inc
  • Cerba Healthcare SA
  • Cerberus Diagnostics Inc
  • Charles River Laboratories International Inc
  • Element Materials Technology Ltd
  • Eurofins Scientific SE
  • Fulgent Genetics Inc
  • ICON plc
  • Intertek Group plc
  • IQVIA Holdings Inc
  • Labcorp Holdings Inc
  • Mayo Foundation for Medical Education and Research
  • Medpace Holdings Inc
  • NeoGenomics Laboratories Inc
  • OPKO Health Inc
  • PPD Inc
  • Quest Diagnostics Incorporated
  • SGS SA
  • Sonic Healthcare Limited
  • SYNLAB AG
  • TÜV SÜD AG
  • Unilabs Holding SA
  • WuXi AppTec Co Ltd

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.84 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Routine Health Screening Market Report 2025 - Product Image

Routine Health Screening Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cellular Health Testing - Global Strategic Business Report - Product Image

Cellular Health Testing - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Cervical Cancer Diagnostic Market - Global Forecast 2026-2032 - Product Image

Cervical Cancer Diagnostic Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
2024 Diagnostics Research Review - Product Image

2024 Diagnostics Research Review

  • Report
  • 458 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.